Results 11 to 20 of about 20,046 (138)

Use of Contrave, Naltrexone with Bupropion, Bupropion, or Naltrexone and Major Adverse Cardiovascular Events: A Systematic Literature Review

open access: yesDiabetes, Metabolic Syndrome and Obesity, 2022
Sarah Dahlberg,1 Ellen T Chang,1 Sheila R Weiss,1 Pamela Dopart,1 Errol Gould,2 Mary E Ritchey3 1Exponent, Inc, Menlo Park, CA, 94025, USA; 2Currax Pharmaceuticals LLC., Brentwood, TN, 37027, USA; 3Med Tech Epi, LLC., Philadelphia, PA, 19147 ...
Dahlberg S   +5 more
doaj  

Desipramin, Venlafaksin ve Bupropionun Farelerdeki Depresyon ve Anksiyete Üzerine Etkilerinin Zorunlu Yüzme Testi ve Yükseltilmiş Artı Labirent Testi ile Değerlendirilmesi

open access: yesSakarya Tıp Dergisi, 2018
Bu çalışmada, farelerde desipramin, venlafaksin ve bupropiyonun depresyon ve anksiyete üzerine etkilerini araştırmayı amaçladık. Klasik trisiklik antidepresan, desipramin, serotonin-norepinefrin geri alım inhibitörü venlafaksin ve ikinci jenerasyon ...
Mehmet Emin Büyükokuroğlu   +6 more
doaj   +1 more source

Is There a Potential of Misuse for Venlafaxine and Bupropion?

open access: yesFrontiers in Pharmacology, 2018
Objective: Traditionally, studies on the non-medical use of pharmaceutical products have focused on controlled substances; e.g., opiates/opioids; and benzodiazepines.
Fabrizio Schifano, Stefania Chiappini
doaj   +1 more source

Prediction of Drug-Drug Interactions with Bupropion and Its Metabolites as CYP2D6 Inhibitors Using a Physiologically-Based Pharmacokinetic Model

open access: yesPharmaceutics, 2017
The potential of inhibitory metabolites of perpetrator drugs to contribute to drug-drug interactions (DDIs) is uncommon and underestimated. However, the occurrence of unexpected DDI suggests the potential contribution of metabolites to the observed DDI ...
Caifu Xue, Xunjie Zhang, Weimin Cai
doaj   +1 more source

Peptic Ulcer Disease Following Use of Bupropion: A Case Report

open access: yesClinical Medicine Insights: Case Reports, 2023
Background: Bupropion is a dopamine reuptake inhibitor, which is prescribed as an effective drug for the treatment of depression and as a complementary drug for smoking cessation in more than 50 countries.
Zahra Momayez Sanat   +2 more
doaj   +1 more source

The association of COMT genotype with buproprion treatment response in the treatment of major depressive disorder

open access: yesBrain and Behavior, 2020
Background Pharmacodynamics and pharmacogenetics are being explored in pharmacological treatment response for major depressive disorder (MDD). Interactions between genotype and treatment response may be dose dependent.
Jay Fawver   +4 more
doaj   +1 more source

Galactorrhoea as a side effect due to Bupropion- a case report

open access: yesEuropean Psychiatry, 2021
Introduction Bupropion is a NDRI antidepressant with action on both serotonin and nicotinic receptors. Endocrine and sexual adverse effects are very rare and hence very unlikely to cause hyperprolactinemia.
D. Bhandutia, S. Nayok
doaj   +1 more source

Bupropion perceived as a stimulant by two patients with a previous history of cocaine misuse

open access: yesAnnali dell'Istituto Superiore di Sanità, 2013
BACKGROUND AND OBJECTIVE: Despite animal studies having shown a generalisation of the bupropion cue to cocaine, this drug has been used in cocaine abuse with mixed results. We here aimed at describing two cases which contradict current knowledge.
Alessandro E. Vento   +6 more
doaj   +1 more source

Seizure Induced by Extended-Release Bupropion Used for Smoking Cessation at Early Term and Therapeutic Dose

open access: yesArchives of Epilepsy, 2018
Bupropion inhibits reuptakes of dopamine and noradrenaline. Since it is also a nicotine receptor antagonist, it acts as a drug used for smoking cessation. Bupropion is commonly preferred because of no side effects on weight, sexual function, and the lack
Zeynep ÖZÖZEN AYAS   +1 more
doaj   +1 more source

Effectiveness of bupropion on sexual dysfunction of women with multiple sclerosis: A Clinical Trial [PDF]

open access: yesMajallah-i Zanān, Māmā̓ī va Nāzā̓ī-i Īrān, 2021
Introduction: Sexual dysfunctions are relatively prevalent in female patients with multiple sclerosis (MS) and affect their quality of life. This study was performed with aim to evaluate the effect of Bupropion on sexual function in women with multiple ...
Farzaneh Yavari   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy